Royal Bank of Canada (NY:RY)

195.67 +0.31 (+0.16%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

59 60 Next >

1 Canadian Stock Ready to Rise in 2026 ↗

May 29, 2026

A hybrid utility stock and energy exporter stands ready to rise further in 2026.

Via The Motley Fool

Topics Artificial Intelligence

An Ideal TFSA Stock With a Steady 4.7% Yield ↗

May 29, 2026

A top Canadian REIT with a proven dividend track record and steady yield is an ideal holding in a TFSA.

Via The Motley Fool

Topics Artificial Intelligence

Why Are Asana (ASAN) Shares Soaring Today

May 29, 2026

What Happened? Shares of work management platform Asana (NYSE:ASAN) jumped 12.7% in the afternoon session after the company reported an impressive “beat and ...

Via StockStory

Topics Artificial Intelligence

Royal Bank (RY) Q2 2026 Earnings Transcript ↗

May 29, 2026

Royal Bank (RY) Q2 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Ferrari Launches Most Polarizing Vehicle in History -- It's Time to Buy the Stock ↗

May 29, 2026

Ferrari is again zigging when rivals zag, and unveiled its first full-electric vehicle recently -- but will the gamble reward investors?

Via The Motley Fool

Is GE Aerospace Stock Outperforming the S&P 500?

May 29, 2026

Having outpaced the S&P 500 Index over the past year, GE Aerospace continues to garner strong analyst support.

Via Barchart.com

Topics Stocks

Prediction: The Pullback in This Canadian Bank Stock Is a Buying Opportunity ↗

May 28, 2026

RBC doesn’t need a perfect economy to reward long-term investors – it needs a fear-driven dip that doesn’t break its fundamentals.

Via The Motley Fool

Topics Artificial Intelligence Economy

RBC Just Upped Its Price Target on Marvell Technology Stock. Here's Why

May 28, 2026

Marvell stock gains as robust Q1 earnings makes RBC raise its price target to $240. Here’s why the investment firm is bullish on MRVL shares.

Via Barchart.com

Topics Artificial Intelligence Supply Chain

Why Veeva Systems (VEEV) Stock Is Up Today

May 28, 2026

What Happened? Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) jumped 3.8% in the afternoon session after the company announced tha...

Via StockStory

Topics Artificial Intelligence

Royal Bank Of Canada Q2 Earnings Call Highlights ↗

May 28, 2026

Royal Bank Of Canada (NYSE:RY) reported fiscal second-quarter earnings of CAD 5.5 billion, with adjusted earnings of CAD 5.6 billion, as management highlighted strong results across capital markets,...

Via MarketBeat

Topics Earnings World Trade

Are Wall Street Analysts Predicting FactSet Research Systems Stock Will Climb or Sink?

May 27, 2026

As FactSet Research Systems has notably lagged the broader market over the past 52 weeks, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Via Barchart.com

Topics ETFs Supply Chain

Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance ↗

May 27, 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) executives said the rare disease company is entering a catalyst-heavy period, with recent positive clinical updates, ongoing commercial momentum for LIVMARLI and...

Via MarketBeat

M&T Bank Stock: Is Wall Street Bullish or Bearish?

May 26, 2026

M&T Bank has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Via Barchart.com

Topics ETFs

Kymera Therapeutics Stays on Track With KT-621 Trials, Teases IRF5 Data ↗

May 26, 2026

Kymera Therapeutics (NASDAQ:KYMR) executives said the company remains on track with key clinical timelines for its lead degrader programs, including KT-621 in atopic dermatitis and asthma, while...

Via MarketBeat

Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst ↗

May 25, 2026

Opus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within...

Via MarketBeat

Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts ↗

May 25, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) highlighted a busy slate of regulatory decisions, clinical readouts and partnered programs during a presentation at RBC Capital Markets’ Global Healthcare...

Via MarketBeat

A Canadian Energy Stock Ready to Bring in the Heat in 2026 ↗

May 25, 2026

Cenovus Energy is a strong buy in 2026 for its massive free cash flow and refining power.

Via The Motley Fool

Topics Artificial Intelligence

The Best Canadian Stocks to Own During a Trade War ↗

May 25, 2026

Three Canadian stocks are the top buys for investors seeking built-in defences during a trade war.

Via The Motley Fool

Topics Artificial Intelligence World Trade

Do Wall Street Analysts Like Air Products and Chemicals Stock?

May 25, 2026

Despite Air Products and Chemicals' underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Via Barchart.com

Topics ETFs Supply Chain

3 Market-Beating Stocks on Our Watchlist

May 25, 2026

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that ca...

Via StockStory

Topics Artificial Intelligence

2 Stocks That Could Turn $100,000 Into $1 Million ↗

May 24, 2026

Two stocks and an income-and-growth strategy could turn $100,000 into a seven-figure fortune over time.

Via The Motley Fool

Topics Artificial Intelligence

Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference ↗

May 24, 2026

Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined several upcoming clinical and regulatory priorities across oncology, inflammation and HIV during a discussion with RBC...

Via MarketBeat

Exelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch Near ↗

May 23, 2026

Exelixis (NASDAQ:EXEL) remains focused on expanding its CABO franchise while preparing for potential launches and data readouts tied to zanzalintinib, Andrew Peters, the company’s senior vice president...

Via MarketBeat

Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise ↗

May 22, 2026

Cytokinetics (NASDAQ:CYTK) executives said the commercial launch of MYKORZO is tracking ahead of internal expectations, while also highlighting positive physician feedback on the drug’s label, REMS...

Via MarketBeat

Are Wall Street Analysts Predicting Cboe Global Markets Stock Will Climb or Sink?

May 22, 2026

Cboe Global Markets has considerably outperformed the broader market over the past 52 weeks, yet Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Via Barchart.com

Topics Derivatives ETFs

Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential ↗

May 22, 2026

Contineum Therapeutics (NASDAQ:CTNM) President and Chief Executive Officer Carmine Stengone said the company remains focused on advancing PIPE-791 in idiopathic pulmonary fibrosis, while recent...

Via MarketBeat

Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout ↗

May 22, 2026

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ASCO meeting, including the first...

Via MarketBeat

5 Must-Read Analyst Questions From RBC Bearings’s Q1 Earnings Call

May 22, 2026

RBC Bearings delivered first quarter results that surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market responded negatively. Mana...

Via StockStory

Topics Earnings

Sprout Social and Veeva Systems Shares Plummet, What You Need To Know

May 21, 2026

What Happened? A number of stocks fell in the afternoon session after Intuit's plunge spread across the sector and reignited the thesis that generative AI is...

Via StockStory

Topics Artificial Intelligence

Asana, Atlassian, and BlackLine Shares Are Falling, What You Need To Know

May 21, 2026

What Happened? A number of stocks fell in the afternoon session after Intuit's plunge spread across the sector and reignited the thesis that generative AI is...

Via StockStory

Topics Artificial Intelligence

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.